John LaMattina, Contributor

Author's posts

There Go Those Drug Companies Inventing New Diseases Again

The biopharmaceutical industry isn’t perfect. But let’s stop with the nonsense that the industry invents diseases. It’s not true.

Pharma R&D Investments Moderating, But Still High

However, it is clear that the pharmaceutical industry is going to continue to invest in R&D at a pretty healthy rate for the foreseeable future.

A Story Of Devastation And Rebirth: The Former Pfizer Research Labs In Ann Arbor

The University of Michigan has provided a blueprint for how to take a difficult situation and convert it into a terrific growth story.